Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: United States Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20051
20063
20072
20084
20091
20102
20113
20124
20134
20142
20158
201610
201712
201821
201918
20208
20214
20223
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed119

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Bristol-Myers Squibb5
Memorial Sloan Kettering Cancer Center5
H. Lee Moffitt Cancer Center and Research Institute4
Incyte Corporation4
Xencor, Inc.4
Eli Lilly and Company3
Incyte Biosciences International Sàrl3
Pacific Edge Limited3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell119
Urinary Bladder Neoplasms47
Carcinoma, Non-Small-Cell Lung34
Melanoma23
Squamous Cell Carcinoma of Head and Neck22
Carcinoma, Renal Cell20
Colorectal Neoplasms16
Carcinoma, Hepatocellular13
Neoplasm Metastasis13
Stomach Neoplasms13

Trials

Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.